CNBCさんのインスタグラム写真 - (CNBCInstagram)「The coronavirus vaccine being developed by the University of Oxford and British pharmaceutical giant AstraZeneca is safe and triggers a similar immune response among all adults, according to the preliminary findings of a peer-reviewed phase two trial.⁠ ⁠ The study of 560 healthy adults, including 240 over age 70, found the vaccine to be safe and produced a similar immune response among people over 56 and those aged 18 to 55.⁠ ⁠ “We’re really delighted with the results,” professor Andrew Pollard, the head of Oxford’s vaccine trial team, told reporters Thursday.⁠ ⁠ The authors of the Oxford study said their results could be encouraging if the immune responses are found to be associated with protection against Covid-19 infection. The phase two trial did not assess vaccine efficacy, however, and phase three trials are ongoing to confirm this.⁠ ⁠ A safe and effective vaccine is seen by many as a game changer in the battle against the coronavirus pandemic.⁠ ⁠ Full story at the link in bio.」11月20日 1時32分